Koninklijke DSM N.V. financials
Koninklijke DSM N.V.
724500SNT1MK246AHP04 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €8.39B | €7.27B |
| Cost of sales | €5.70B | €4.66B |
| Gross profit | €2.69B | €2.61B |
| Operating profit (EBIT) | €682.0M | €711.0M |
| Finance costs | €159.0M | €124.0M |
| Profit before tax | €594.0M | €611.0M |
| Income tax expense | €124.0M | €123.0M |
| Profit for the year | €1.72B | €1.68B |
| — attributable to NCI | €15.0M | €4.0M |
| Total comprehensive income | €1.94B | €2.32B |
| Per share | ||
| Basic EPS | €9.80 | €9.68 |
| Diluted EPS | €9.77 | €9.63 |
| Cash flow statement | ||
| Dividends paid | €459.0M | €424.0M |
| Balance sheet | ||
| Total assets | €17.40B | €16.02B |
| Non-current assets | €9.28B | €9.89B |
| Property, plant & equipment | €3.58B | €3.96B |
| Intangible assets & goodwill | €5.15B | €5.31B |
| Current assets | €8.13B | €6.13B |
| Inventories | €2.34B | €2.30B |
| Trade & other receivables | €1.51B | €1.60B |
| Cash & equivalents | €2.75B | €1.56B |
| Total equity | €10.85B | €9.40B |
| — attributable to owners | €10.74B | €9.32B |
| Non-controlling interests | €102.0M | €79.0M |
| Non-current liabilities | €3.98B | €4.19B |
| Long-term borrowings | €2.98B | €3.00B |
| Current liabilities | €2.58B | €2.43B |
| Short-term borrowings | €86.0M | €103.0M |
| Deferred tax liabilities | €476.0M | €490.0M |
| Derived metrics | ||
| Operating margin | 8.1% | 9.8% |
| Net margin | 20.4% | 23.1% |
| Return on equity | 15.8% | 17.9% |
| Other reported items | ||
| Basic Earnings Loss Per Share From Continuing Operations | €2.64 | €4.76 |
| Cancellation of Treasury Shares | — | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €12.0M | €12.0M |
| Comprehensive Income Attributable To Owners of Parent | €1.93B | €2.31B |
| Current Derivative Financial Assets | €42.0M | €30.0M |
| Current Derivative Financial Liabilities | €23.0M | €40.0M |
| Current Investments | €125.0M | €489.0M |
| Current Provisions | €50.0M | €68.0M |
| Current Recognised Liabilities Defined Benefit Plan | €22.0M | €21.0M |
| Current Tax Assets Current | €36.0M | €61.0M |
| Current Tax Liabilities Current | €64.0M | €77.0M |
| Deferred Tax Assets | €95.0M | €203.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | €2.63 | €4.74 |
| Equity and Liabilities | €17.40B | €16.02B |
| Finance Income | €71.0M | €24.0M |
| Gains Losses On Cash Flow Hedges Before Tax | -€6.0M | -€24.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | €267.0M | €478.0M |
| General and Administrative Expense | €534.0M | €475.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €7.0M | -€7.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €10.0M | €20.0M |
| Increase Decrease Through Acquisition of Subsidiary | -€4.0M | -€24.0M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | -€13.0M |
| Increase Decrease Through Treasury Share Transactions | €141.0M | €193.0M |
| Investment Accounted For Using Equity Method | €61.0M | €64.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €430.0M | €10.0M |
| Miscellaneous Other Operating Expense | €51.0M | €62.0M |
| Miscellaneous Other Operating Income | €107.0M | €82.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €1.25B | €56.0M |
| Noncurrent Derivative Financial Assets | €82.0M | €48.0M |
| Noncurrent Derivative Financial Liabilities | €4.0M | €9.0M |
| Noncurrent Provisions | €74.0M | €96.0M |
| Noncurrent Recognised Assets Defined Benefit Plan | €19.0M | €75.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €241.0M | €323.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€61.0M | €46.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €10.0M | €153.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €291.0M | €456.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€64.0M | €187.0M |
| Other Current Liabilities | €490.0M | €540.0M |
| Other Current Receivables | €78.0M | €32.0M |
| Other Noncurrent Financial Assets | €295.0M | €227.0M |
| Other Noncurrent Liabilities | €205.0M | €280.0M |
| Profit Loss Attributable To Ordinary Equity Holders of Parent Entity | €1.69B | €1.67B |
| Profit Loss From Continuing Operations | €475.0M | €830.0M |
| Profit Loss From Discontinued Operations | €1.24B | €850.0M |
| Purchase of Treasury Shares | €210.0M | €165.0M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -€53.0M | -€7.0M |
| Reclassification Adjustments On Exchange Differences On Translation Before Tax | €16.0M | €13.0M |
| Research and Development Expense | €295.0M | €274.0M |
| Sales and Marketing Expense | €1.24B | €1.17B |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | €0 | €1.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €12.0M | €16.0M |
| Trade and Other Current Payables To Trade Suppliers | €1.42B | €1.57B |
Every line item above is a fact tagged in Koninklijke DSM N.V.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.